Efficient score statistic in drug and vaccine safety surveillance
From MaRDI portal
Publication:4982003
DOI10.1080/07474946.2015.995990zbMATH Open1309.62139OpenAlexW2037020249MaRDI QIDQ4982003FDOQ4982003
Publication date: 23 March 2015
Published in: Sequential Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/07474946.2015.995990
Recommendations
- Editor's special invited paper: On the efficient score vector in sequential monitoring
- A maximized sequential probability ratio test for drug and vaccine safety surveillance
- Continuous post-market sequential safety surveillance with minimum events to signal
- A likelihood ratio test based method for signal detection with application to FDA's drug safety data
- Exact conditional maximized sequential probability ratio test adjusted for covariates
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Sequential statistical analysis (62L10)
Cites Work
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance
- Title not available (Why is that?)
- Monitoring parameter change in AR\((p)\) time series models
- The weighted sequential likelihood ratio
- Detection of a “Disorder” in a Wiener Process
- Sequential Change-Point Detection and Estimation
- Title not available (Why is that?)
Cited In (3)
- Editor’s special invited paper: On the efficient score vector in sequential monitoring
- Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
This page was built for publication: Efficient score statistic in drug and vaccine safety surveillance
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4982003)
